Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Walcher

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Progress in Lipid Research|July 20, 2007
Vascular effects of PPARgamma activators - from bench to bedsideNikolaus Marx, Daniel Walcher
Diabetes & Vascular Disease Research|November 24, 2005
Insulin resistance and cardiovascular disease: the role of PPARgamma activators beyond their anti-diabetic actionDaniel Walcher, Nikolaus Marx
Mediators of Inflammation|May 2, 2012
C-peptide: a new mediator of atherosclerosis in diabetesDusica Vasic, Daniel Walcher
The Review of Diabetic Studies : RDS|December 30, 2009
C-Peptide in the vessel wallDaniel Walcher, Nikolaus Marx
Experimental Diabetes Research|April 11, 2008
C-Peptide and atherogenesis: C-Peptide as a mediator of lesion development in patients with type 2 diabetes mellitus?Nikolaus Marx, Daniel Walcher
International Journal of Inflammation|July 5, 2012
Proinflammatory effects of C-Peptide in different tissuesDusica Vasic, Daniel Walcher
Seminars in Immunopathology|April 7, 2009
Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesisDaniel Walcher, Nikolaus Marx
Clinical Case Reports|November 21, 2017
Percutaneous mitral valve repair with the MitraClip NT™ system in a patient presenting with prolonged cardiogenic shockDominik Buckert, Sinisa Markovic, Markus Kunze, et al.
Biomolecules|November 17, 2019
Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated CardiomyopathyKarolina Weinmann, Jakob Werner, Wolfgang Koenig, et al.
Biomolecules|November 8, 2018
Add-on Immunoadsorption Shortly-after Optimal Medical Treatment Further Significantly and Persistently Improves Cardiac Function and Symptoms in Recent-Onset Heart Failure-A Single Center ExperienceKarolina Weinmann, Jakob Werner, Wolfgang Koenig, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Progress in Lipid Research|July 20, 2007
Vascular effects of PPARgamma activators - from bench to bedsideNikolaus Marx, Daniel Walcher
Diabetes & Vascular Disease Research|November 24, 2005
Insulin resistance and cardiovascular disease: the role of PPARgamma activators beyond their anti-diabetic actionDaniel Walcher, Nikolaus Marx
Mediators of Inflammation|May 2, 2012
C-peptide: a new mediator of atherosclerosis in diabetesDusica Vasic, Daniel Walcher
The Review of Diabetic Studies : RDS|December 30, 2009
C-Peptide in the vessel wallDaniel Walcher, Nikolaus Marx
Experimental Diabetes Research|April 11, 2008
C-Peptide and atherogenesis: C-Peptide as a mediator of lesion development in patients with type 2 diabetes mellitus?Nikolaus Marx, Daniel Walcher
International Journal of Inflammation|July 5, 2012
Proinflammatory effects of C-Peptide in different tissuesDusica Vasic, Daniel Walcher
Seminars in Immunopathology|April 7, 2009
Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesisDaniel Walcher, Nikolaus Marx
Clinical Case Reports|November 21, 2017
Percutaneous mitral valve repair with the MitraClip NT™ system in a patient presenting with prolonged cardiogenic shockDominik Buckert, Sinisa Markovic, Markus Kunze, et al.
Biomolecules|November 17, 2019
Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated CardiomyopathyKarolina Weinmann, Jakob Werner, Wolfgang Koenig, et al.
Biomolecules|November 8, 2018
Add-on Immunoadsorption Shortly-after Optimal Medical Treatment Further Significantly and Persistently Improves Cardiac Function and Symptoms in Recent-Onset Heart Failure-A Single Center ExperienceKarolina Weinmann, Jakob Werner, Wolfgang Koenig, et al.
Pageof 4